Home LiteratureArticle Details
PMID: 10719303 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

CD40 and adenosine A2 receptor agonist-cyclic adenosine monophosphate rescue B-cell antigen receptor-induced apoptosis through independent pathways and converge to prevent caspase activation.

The Journal of allergy and clinical immunology ·Vol. 105 ·No. 3 ·2000-03-00 ·Pages 522-31

Sakata N, Kawasome H, Terada N, Johnson GL, Gelfand EW

Abstract

Antigen receptor ligation induces apoptosis of B lymphocytes, but the molecular mechanisms underlying induction of apoptosis remain unclear, although the growing family of IL-1beta-converting enzyme cysteine proteases (caspases) are recognized to be major effectors of cellular death. We sought to delineate and compare the rescue of B-cell apoptosis through CD40 ligand-CD40 interaction and cyclic adenosine monophosphate (cAMP)-dependent protein kinase A in human B cells. By using tonsillar B cells and the B-lymphoblastoid cell line Ramos, rescue from B-cell apoptosis was compared, as were signaling pathways after activation of cells through CD40 and the adenosine A2 receptor. Both CD40 ligand-CD40 interaction and activation of intracellular cAMP rescue B cells from apoptosis after antigen receptor ligation. Although these pathways do not overlap, they converge by preventing the anti-IgM-induced activation of CPP32 (caspase 3), a member of the IL-1beta-converting enzyme protease family. These data indicate that the cAMP-protein kinase A-dependent and CD40-signaling pathways regulate B-cell survival and converge at a common point, the inhibition of antigen receptor-induced activation of caspases.

MeSH Terms
Antibodies/pharmacology Antibodies, Anti-Idiotypic/pharmacology Apoptosis/drug effects B-Lymphocytes/cytology Bucladesine CD40 Antigens/immunology,pharmacology Caspases/metabolism Cyclic AMP/pharmacology Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors,metabolism Cysteine Proteinase Inhibitors/pharmacology Enzyme Activation/drug effects Humans Mitogen-Activated Protein Kinases/metabolism Proto-Oncogene Proteins c-bcl-2/biosynthesis Purinergic P1 Receptor Agonists Receptors, Antigen, B-Cell/antagonists & inhibitors,physiology Tumor Cells, Cultured
Chemicals
Antibodies Antibodies, Anti-Idiotypic CD40 Antigens Cysteine Proteinase Inhibitors Proto-Oncogene Proteins c-bcl-2 Purinergic P1 Receptor Agonists Receptors, Antigen, B-Cell anti-IgM Bucladesine Cyclic AMP Cyclic AMP-Dependent Protein Kinases Mitogen-Activated Protein Kinases Caspases
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Sakata N
Division of Basic Sciences, Department of Pediatrics, Program in Molecular Signal Transduction, National Jewish Medical and Research Center, Denver, CO, USA.
Kawasome H
Terada N
Johnson G L
Gelfand E W
Article Info
Journal
The Journal of allergy and clinical immunology
Abbr.
J Allergy Clin Immunol
ISSN
0091-6749
Published
2000-03-00
Pages
522-31
Language
English
Region
United States
NLM ID
1275002
Subset
IM
Grants
NIAID NIH HHS · AI HL-36577 · United States
NIDDK NIH HHS · DK-37871 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com